Evidence map›Paper›PMID 25288300›Full record

ArticleJournal of neuroimmunology2014

RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis.

Nicholas E Martinez, Fumitaka Sato, Seiichi Omura, Eiichiro Kawai, Satoru Takahashi, Keigyou Yoh, Ikuo Tsunoda

Abstract read
In one paragraph

Article in Journal of neuroimmunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Oxysterols in Autoimmunity.International journal of molecular sciences · 2019
    Review
  8. Article
  9. Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2018
    Article
  10. Article
  11. Clinical & experimental neuroimmunology · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Nicholas E MartinezDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Fumitaka SatoDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Seiichi OmuraDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Eiichiro KawaiDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA.
Satoru TakahashiDepartment of Anatomy and Embryology, Faculty of Medicine, International Institute for Integrative Sleep Medicine (WPI-IIIS), Life Science Center, Tsukuba Research Alliance (TARA), Laboratory Animal Resource Center (LARC), University of Tsukuba, Tsukuba, Ibaraki, 305-8575, Japan.
Keigyou YohDepartment of Nephrology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, 305-8575, Japan.
Ikuo TsunodaDepartment of Microbiology and Immunology, Center for Molecular and Tumor Virology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA. Electronic address: itsuno@lsuhsc.edu.
Louisiana State University Health Sciences Center Shreveport · USTsukuba International University · JPUniversity of Tsukuba Hospital · JP

Funding

COBRE Center for Molecular and Tumor VirologyP30GM110703 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI SAPP, MARTIN · 2014 to 2018
$4.8M
NIGMS NIH HHS P30 GM110703NIGMS NIH HHS P30-GM110703
6 · The paper itself

Abstract

Th17 cells play an important role in multiple sclerosis (MS) and its autoimmune model, experimental autoimmune encephalomyelitis (EAE). However, studies have not addressed how enhanced Th17 immune responses can affect demyelinating diseases. We induced EAE with MOG in RORγt transgenic C57BL/6 mice that overexpress a Th17 inducing transcription factor. RORγt transgenic mice developed more severe EAE than wild-type mice with more robust anti-MOG Th17 immune responses. In contrast, mice overexpressing T-bet, a Th1-inducing transcription factor, were resistant to EAE. Therefore, a genetic bias toward Th17 immune responses could contribute to CNS immunopathology.

Indexed as

AnimalsCell ProliferationCentral Nervous SystemDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalFlow CytometryLeukocytes, MononuclearMiceMice, Inbred C57BLMice, TransgenicMultiple SclerosisNuclear Receptor Subfamily 1, Group F, Member 3T-bet Transcription FactorT-Box Domain ProteinsTh1 CellsNuclear Receptor Subfamily 1, Group F, Member 3T-bet Transcription FactorT-Box Domain ProteinsAutoimmune diseaseDemyelinating diseaseGain-of-functionGenetic associationT cell differentiation

Identifiers

PMID25288300
PMCPMC4252371
OpenAlexW2036998093

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.